New research conducted at the Ingham Institute for Applied Medical Research in Liverpool, New South Wales, has found a new approach to treating pancreatic cancer. The research, published in Oncotarget, suggests that a combined approach that targets tumor cells with chemotherapy while inhibiting specific pathways that mediate stromal-tumor interactions may represent a novel therapeutic strategy… [Read More]
A new study released by our 2016-17 Seed Grant Awardee, Nada Kalaany, PhD shows evidence that targeting an enzyme that tumors use to get rid of nitrogen can slow tumor growth. These innovative therapeutic strategies are precisely why our Seed Grant Program is crucial in the fight against pancreatic cancer.
… [Read the entire story]
Originally published at http://www.cancer.ucla.edu UCLA scientists combine a peptide with a nano cancer drug formulation to improve treatment effectiveness and prevent metastasis in pancreatic cancer Study shows the peptide enhances a vascular access pathway for nanocarriers in pancreatic cancer UCLA scientists have unlocked an important mechanism that allows chemotherapy-carrying nanoparticles—extremely small objects between 1 and 100… [Read More]
We’re happy to announce that the video presentations of the 13th annual Symposium on Pancreatic Cancer are now available to view on our website. This year the Symposium was titled, ‘Mission to Cure Pancreatic Cancer’ and when you hear the speakers you’ll share our confidence that our esteemed doctors and scientists are truly making a… [Read More]
David Gius, MD, PhD from Northwestern University was funded in the 2012 cycle of the Hirshberg Foundation’s annual Seed Grant Program. The results of the study explain the genetic connection between aging and cancer. Gius is the Vice Chair of Translation Research in the Department of Radiation Oncology and Pharmacology at Northwestern University Feinberg School… [Read More]
2011 Seed Grant Recipient Ido Wolf, MD from University of Tel Aviv, Israel, recently published his findings that will offer novel approaches towards development of new therapies for pancreatic cancer. Dr. Wolf, Head of Oncology Research Laboratory at Tel Aviv Sourasky Medical Center has been investigating the role of klotho in pancreatic cancer. Klotho is… [Read More]